Products for Research Use Only
RegisterLogin

Sweroside (Standard)

CAT: 0804-HY-N0806R-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N0806R-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Sweroside (Standard) is the analytical standard of Sweroside. This product is intended for research and analytical applications. Sweroside is an iridoid glycoside that targets multiple targets, including the Keap1/Nrf2 axis, NLRP3 inflammasome, SIRT1, NF-κB, AMPK/mTOR pathway, and caspase family. Sweroside promotes Nrf2 nuclear translocation by competitively binding to Keap1. Sweroside also inhibits oxidative stress and NLRP3-mediated pyroptosis by activating Nrf2, inhibits NF-κB inflammatory pathway by activating SIRT1, and promotes autophagy and induces caspase-dependent apoptosis via the AMPK/mTOR pathway. Sweroside has antioxidant, anti-inflammatory, anti-apoptotic, and lipid metabolism regulating activities, and can be used in the research of myocardial ischemia-reperfusion injury, leukemia, acute lung injury, non-alcoholic fatty liver disease, and other fields[1][2][3][4].
CAS Number
14215-86-2
UNSPSC
12352005
Target
AMPK; Apoptosis; Autophagy; Keap1-Nrf2; NF-κB; NOD-like Receptor (NLR) ; PARP; Pyroptosis; Reference Standards; Sirtuin
Type
Reference Standards
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; NF-κB; Others; PI3K/Akt/mTOR
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/sweroside-standard.html
Smiles
C=C[C@@H]1[C@@](CCOC2=O)([H])C2=CO[C@H]1O[C@]([C@@H]([C@@H](O)[C@@H]3O)O)([H])O[C@@H]3CO
Molecular Formula
C16H22O9
Molecular Weight
358.34
References & Citations
[1]Li J, et al. Sweroside Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress and Pyroptosis Partially via Modulation of the Keap1/Nrf2 Axis. Front Cardiovasc Med. 2021 Mar 19;8:650368.|[2]Han XL, et al. Sweroside eradicated leukemia cells and attenuated pathogenic processes in mice by inducing apoptosis. Biomed Pharmacother. 2017 Nov;95:477-486.|[3]Wang J, et al. Anti-inflammatory Effects of Sweroside on LPS-Induced ALI in Mice Via Activating SIRT1. Inflammation. 2021 Oct;44 (5) :1961-1968.|[4]Ding Y, et al. Sweroside alleviates hepatic steatosis in part by activating AMPK/mTOR-mediated autophagy in mice. J Cell Biochem. 2023 Jul;124 (7) :1012-1022.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Isoform
NLRP3; SIRT1

Related Products

CatalogName
HY-N0806-01Sweroside
HY-P2274RArgifin (Standard)
HY-N9362REmodinanthrone (Standard)
HY-N7948RIsomaltotetraose (Standard)
HY-N7640RDeoxylimonin (Standard)
HY-N7617RToralactone (Standard)
HY-N7541RAntrodin A (Standard)
HY-N6739RBeauvericin (Standard)
HY-N6687RCalcimycin (Standard)
HY-N3373RLoganetin (Standard)

Alternative Products

CatalogName
464184(−)-Sweroside
BUP00078-01Sweroside
TRC-S885530-10MG(-)-Sweroside
RG-S032000-01(-) -Sweroside
371995Sweroside discontinued
301017Sweroside, 6'-O-β-D-apiofuranosyl-

Popular Products